Clinical Trial Update: Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating liposomal irinotecan-based FOLFIRI with bevacizumab as first-line treatment for advanced colorectal cancer; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Bevacizumab (bevacizumab)
• Leucovorin (folinic acid)
• Liposomal irinotecan (liposomal irinotecan)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING